Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
MeiraGTx Holdings PLC
MGTXCurrent price
5.77 USD
-0.23 USD (-3.83%)
Last closed
5.91 USD
Company
www.meiragtx.com
ISIN
KYG596651029
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
490 803 360 USD
Yield for 12 month
-5.87 %
1Y
3Y
5Y
10Y
15Y
MGTX
MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases, neurodegenerative diseases, and xerostomia. Its programs in clinical development include Phase I/II clinical stage programs in achromatopsia, X-linked retinitis pigmentosa, and RPE65-deficiency; Phase I clinical trials for radiation-induced xerostomia; and Parkinson's program that has completed a Phase II trial. It has a research collaboration agreement with Janssen Pharmaceuticals, Inc. for the research, development, and commercialization of gene therapies for the treatment of inherited retinal disease. The company was incorporated in 2015 and is based in New York, New York. Address: 450 East 29th Street, New York, NY, United States, 10016
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
21.00 USDP/E ratio
–Dividend Yield
–Current Year
+14 017 000 USD
Last Year
+15 920 000 USD
Current Quarter
+10 910 000 USD
Last Quarter
+282 000 USD
Current Year
+14 017 000 USD
Last Year
+7 197 000 USD
Current Quarter
-1 075 000 USD
Last Quarter
-2 940 000 USD
Key Figures MGTX
1 year
3 years
5 years
10 years
EBITDA
-155 308 992 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-36.66 %
PEG Ratio
–
Return On Equity TTM
-91.51 %
Wall Street Target Price
21.00 USD
Revenue TTM
8 122 000 USD
Book Value
2.17 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-92.00 %
Dividend Yield
–
Gross Profit TTM
15 920 000 USD
Earnings per share
-1.20 USD
Diluted Eps TTM
-1.20 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics MGTX
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History MGTX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation MGTX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
2.12
Enterprise Value Revenue
31.74
Price Sales TTM
58.89
Enterprise Value EBITDA
-3.29
Price Book MRQ
5.00
Financials MGTX
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators MGTX
For 52 weeks
3.85 USD
7.60 USD
50 Day MA
5.91 USD
Shares Short Prior Month
1 493 213
200 Day MA
5.14 USD
Short Ratio
4.86
Shares Short
1 484 372
Short Percent
2.97 %
BeatStart